Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?
about
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyLiver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosisPrevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE.Childhood obesity: a life-long health riskNonalcoholic fatty liver disease and cardiovascular diseaseCurrent and Future Burden of Chronic Nonmalignant Liver DiseaseThe relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes.Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopStatins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions.The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice.Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice.Serum and Liver Tissue Metabonomic Study on Fatty Liver in Rats Induced by High-Fat Diet and Intervention Effects of Traditional Chinese Medicine Qushi Huayu Decoction.Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease.Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis.The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis
P2860
Q24612841-CCBE1136-322F-416B-8DB8-1E4936F9744DQ26781753-A9D5D69D-BF52-4F9A-89E6-496F26B4755BQ28586093-AB31154F-ED00-45CF-8549-674E74FBE6CBQ30390099-69F73DA4-FAE6-480E-AF29-9B31098CD2FBQ33567286-9C06D63C-4F79-4CAD-B48F-491EF93DD4EAQ33886952-E9D518FB-ED3F-4CD9-8E5B-FC8E3410F525Q34490300-0E87F69B-6151-40D8-9343-A81EE35CA692Q36470460-5ADC712D-1FA4-4B1F-8F3C-C3537E0EAD67Q36507547-C1847089-6A30-4918-9ADC-B14578AA9E5BQ36750183-FC3CAAD4-A627-4837-BCF7-C1C7DCB5C0E9Q36987260-84DEF968-752C-477F-8410-7C3435C3B982Q37951499-5AF474DE-AFFC-47F5-805C-A2BEAEC94A6BQ38200139-05F954C3-311D-411F-BAC3-7AAFA54EF97EQ38781112-54DAD799-CA74-40F3-B886-800DD0E1677CQ41911004-9E227CF4-7C56-43F7-9290-78A29BA383FEQ42361156-E4958C92-6A1B-4BC2-A384-8B1F6297CAF6Q43709239-59B3A2DE-985B-4389-AC57-C5F6894F414DQ54312430-A58141CB-2D2F-4734-804C-7F04B2F78993Q58147152-14EAF085-3D19-4D7C-A199-BE3392B4D533
P2860
Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-Alcoholic Fatty Liver Dise ...... burden for health authorities?
@en
Non-Alcoholic Fatty Liver Disease
@nl
type
label
Non-Alcoholic Fatty Liver Dise ...... burden for health authorities?
@en
Non-Alcoholic Fatty Liver Disease
@nl
prefLabel
Non-Alcoholic Fatty Liver Dise ...... burden for health authorities?
@en
Non-Alcoholic Fatty Liver Disease
@nl
P1476
Non-Alcoholic Fatty Liver Dise ...... burden for health authorities?
@en
P2093
Emmanuel O Abu
Mohamed H Ahmed
P304
P356
10.1016/J.PCD.2010.02.004
P577
2010-03-17T00:00:00Z